FILE PHOTO: A small shopping basket filled with vials labelled "COVID-19 - Coronavirus Vaccine" and a medical syringe are placed on a Moderna logo in this illustration taken November 29, 2020. REUTERS/Dado Ruvic
ZURICH (Reuters) - Moderna Inc's COVID-19 vaccine, fresh off European approval on Wednesday, must make a long, continent-crossing journey from the Swiss Alps to Spain, France and Belgium before final delivery to the EU's 27 countries.
With few of its own factories, U.S.-based Moderna is reliant on partners -- big contract manufacturers, long-haul truckers, even military recruits enlisted to guard vaccines in secret warehouses -- to get shots to more than 400 million Europeans desperate for pandemic relief.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
